Approved for JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults.. Suzetrigine is a selective blocker of the Na V 1.8 voltage-gated sodium channel, compared to other known voltage-gated sodium channels (Na V 1.1 through 1.9). Na V 1.8 is expressed in peripheral… Side effects, costs, interactions, manufacturer, and generic alternatives…
Loading full data from Know Your Drugs Institute…